CME Sponsor:
Annenberg Center for Health Sciences at Eisenhower

Online Journal CME:
Clarifying Long-Term Management of ACS

Faculty:
Eric R. Bates, MD, FACC
Professor of Internal Medicine
Cardiovascular Division
University of Michigan Medical Center
Ann Arbor, Michigan

James A. de Lemos, MD
Assistant Professor, Internal Medicine
Division of Cardiology
University of Texas Southwestern Medical School
Dallas, Texas

Number of Credits:
1 AMA PRA Category 1 Credit™

Registration Fee:
Free

Intended Audience:
This activity was developed for internists, family physicians, and cardiologists involved in the care of patients post treatment for an acute coronary event.

Statement of Need:
This activity is designed to address the utilization of optimal antiplatelet therapy in maintenance therapy for patients following an acute coronary event.

Learning Objectives:
At the conclusion of this activity, the participant will be able to:
  • Assess a patient’s risk for clotting-related problems post treatment for acute coronary event
  • Appropriately design protocols for individual patients based on assessment of patient risk and treatment risks and benefits
This activity will address professional practice gaps in knowledge and competence.

Accreditation and Certification:
The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Annenberg Center designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

There is no charge for this activity.

Disclosure:
It is the policy of the Annenberg Center to ensure fair balance, independence, objectivity, and scientific rigor in all programming. All faculty and planners participating in sponsored programs are expected to identify and reference off-label product use and disclose any relationship with those supporting the activity or any others with products or services available within the scope of the topic being discussed in the educational presentation.

In accordance with the Accreditation Council for Continuing Medical Education Standards, parallel documents from other accrediting bodies, and Annenberg Center policy, the following disclosures have been made:

Eric R. Bates, MD
Research Support           
Eli Lilly and Company
Consultant
Bristol-Myers Squibb Company
Daiichi-Sankyo
Eli Lilly and Company
Novartis Pharmaceuticals
sanofi-aventis
Takeda Pharmaceticals, Inc.

James A. de Lemos, MD
Research Support
Biosite, Inc.
Consultant 
Biosite, Inc.
Roche
Speakers Bureau
Bristol-Myers Squibb Company
Merck/Schering
Pfizer, Inc.
sanofi-aventis

The faculty for this activity have disclosed that there will be discussion about the use of products for non-FDA approved indications.

The following have no significant relationship to disclose:

Anne Greenberg, medical writer

All staff at the Annenberg Center for Health Sciences at Eisenhower have nothing to disclose. The ideas and opinions presented in this educational activity are those of the faculty and do not necessarily reflect the views of the Annenberg Center and/or its agents. As in all educational activities, we encourage practitioners to use their own judgment in treating and addressing the needs of each individual patient, taking into account that patient’s unique clinical situation. The Annenberg Center disclaims all liability and cannot be held responsible for any problems that may arise from participating in this activity or following treatment recommendations presented.

This activity is supported by an independent educational grant from Daiichi Sankyo Lilly

This activity is an enduring material and consists of an e-newsletter. Successful completion is achieved by reading the material, reflecting on its implications in your practice, and completing the assessment component.

The estimated time to complete the activity is 1 hour.

This activity was originally released in May 2010 and is eligible for credit through April 30, 2011.
This activity was reviewed in May 2011 and is eligible for credit through November 1, 2011.



[ Click the banner above for download]